Solan Headlines

Alcohol Use Disorder Market Size, Share, Trends, Growth, Leading Companies, Emerging Drugs, and Epidemiology Forecast

 Breaking News
  • No posts were found

Alcohol Use Disorder Market Size, Share, Trends, Growth, Leading Companies, Emerging Drugs, and Epidemiology Forecast

March 08
16:45 2021
Alcohol Use Disorder Market Size, Share, Trends, Growth, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Delveinsight Business Research LLP

DelveInsight’s “Alcohol Use Disorder Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Alcohol Use Disorder, historical and forecasted epidemiology as well as the Alcohol Use Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Alcohol use disorder (AUD) is a substance use disorder characterized by excessive, uncontrollable drinking that impacts a person physically, emotionally, and socially. The general population also refers to AUD as alcohol abuse or alcoholism.

The common signs of AUD include uncontrolled alcohol intake, craving for alcohol, etc. A person with AUD may experience withdrawal symptoms such as sweating, rapid heartbeat, hand tremors, problems sleeping, nausea and vomiting, hallucinations, restlessness and agitation, anxiety, and occasionally seizures. The risk factors include trauma, bariatric surgery, mental health problems, starting drinking at an early age, steady drinking over time, social and cultural factors, and family history of AUD.

Get FREE sample copy at: 
https://www.delveinsight.com/sample-request/alcohol-use-disorder-market

The Alcohol Use Disorder market report also covers emerging drugs, current treatment practices, Alcohol Use Disorder market share of the individual therapies, current and forecasted Alcohol Use Disorder Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Alcohol Use Disorder treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 

Alcohol Use Disorder Market

Alcohol Use Disorder Market Key Facts

As per the NHS estimates, “around 9% of men in the UK and 3% of UK women show signs of alcohol dependence”.

As per studies by Psychology Today, 29.1% of the US population has experienced an Alcohol Use Disorder of a varying grade at some point in their lifetime. Also, in a 1-year period, approximately 13.9% of the US population experience an AUD.

According to the National Survey on Drug Use and Health, in 2018, 5.5% of adults aged 18 years and older had AUD. In adolescents, 12–17 years, 1.6% of people suffered from Alcohol Use Disorder.

Key Benefits of Alcohol Use Disorder Market Report

  • Alcohol Use Disorder market report provides an in-depth analysis of Alcohol Use Disorder Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Alcohol Use Disorder market report will help in developing business strategies by understanding the Alcohol Use Disorder Market trends & developments, key players, and future market competition that will shape and drive the Alcohol Use Disorder market in the upcoming years.

  • The Alcohol Use Disorder market report covers Alcohol Use Disorder current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Alcohol Use Disorder market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Alcohol Use Disorder Market

Alcohol Use Disorder (AUD) market size shall grow during the forecast period owing to the launch of upcoming therapies, changing lifestyles, increasing disposable income, and a higher young population.

The Alcohol Use Disorder market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Alcohol Use Disorder market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Alcohol Use Disorder market trend and share of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Alcohol Use Disorder Epidemiology

The Alcohol Use Disorder epidemiology section covers insights about the historical and current Alcohol Use Disorder patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Alcohol Use Disorder Drugs Uptake and Key Market Players

The Alcohol Use Disorder Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alcohol Use Disorder market or expected to get launched in the market during the study period. The analysis covers Alcohol Use Disorder market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The Alcohol Use Disorder (AUD) market size is anticipated to change in the coming years owing to the improvement in the rise in the number of healthcare spending across the world.

Alcohol Use Disorder (AUD) Companies:
Adial Pharmaceuticals
Opiant Pharmaceuticals
Neurelis
Tonix Pharmaceuticals
Odyssey Pharmaceutical
Alkermes
Bayer
And many others.

Alcohol Use Disorder (AUD) Therapies covered in the report include:
AD04
OPNT002
TNX-102 SL
And many others.

Table of Content

1. Key Insights

2. Executive Summary 

3. Alcohol Use Disorder Competitive Intelligence Analysis

4. Alcohol Use Disorder Market Overview at a Glance

5. Alcohol Use Disorder Disease Background and Overview

6. Alcohol Use Disorder Patient Journey

7. Alcohol Use Disorder Epidemiology and Patient Population

8. Alcohol Use Disorder Treatment Algorithm, Current Treatment, and Medical Practices

9. Alcohol Use Disorder Unmet Needs

10. Key Endpoints of Alcohol Use Disorder Treatment

11. Alcohol Use Disorder Marketed Products

12. Alcohol Use Disorder Emerging Therapies

13. Alcohol Use Disorder Seven Major Market Analysis

14. Attribute Analysis

15. Alcohol Use Disorder Market Outlook (7 major markets)

16. Alcohol Use Disorder Access and Reimbursement Overview

17. KOL Views on the Alcohol Use Disorder Market.

18. Alcohol Use Disorder Market Drivers

19. Alcohol Use Disorder Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Other Latest Report By Delveinsight –
Lamellar Ichthyosis Market Forecast
DelveInsight’ s “Lamellar Ichthyosis Market Insights, Epidemiology, and Market Forecast 2030” report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology and the Lamellar Ichthyosis market size, share, trends, and forecast for the seven major markets (i.e. the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles